Glomerulosclerosis: insights into pathogenesis and treatment.
el Nahas
A M
AM
Department of Renal Medicine, Northern General Hospital, Sheffield, UK.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004044:Dietary Proteins / Q000008:administration & dosage; D005921:Glomerulonephritis / Q000209:etiology*; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D006977:Hypertension, Renal / Q000150:complications* / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D051381:Rats
D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D004044:Dietary Proteins; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors